Cheaper Ozempic arrives: Dr Reddy’s launches generic semaglutide after patent expiry

Dr Reddy’s Laboratories has launched India’s first generic semaglutide injection for Type 2 diabetes, following patent expiry of the original drug. Priced at about ₹4,200 per month, it offers a more affordable option for patients. The once-weekly injection helps control blood sugar and supports weight loss, potentially expanding access to advanced diabetes care for millions in India.
Share this Video

READ MORE:

dr reddy semaglutide india |obeda injection india |diabetes treatment india |weight loss diabetes drug |affordable diabetes medicine india |semaglutide price india |blood sugar control medicine |new diabetes drug india |pharma news india |obesity treatment india
appinstlBnr
Business News › News › India › Cheaper Ozempic arrives: Dr Reddy’s launches generic semaglutide after patent expiry
Open in App

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Download ET APP


Follow us on


Powered by

become a member

Terms of Use & Grievance Redressal Policy
DNPA Code of Ethics|Privacy Policy|Archive|Delete Data|Feedback|

Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service

Do Not Sell My Personal Information
Success
This article has been saved